The latest on a push to wield march-in rights; president of generic drug lobby ousted

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by       STAT+: A year after petition, NIH will finally review request to lower cancer drug's cost by sidestepping patents By Ed Silverman Adobe “A rejection of the petition will encourage more aggressive pricing of drugs," wrote two cancer patients to the HHS. Read More STAT+: AAM's Dan Leonard, president of generic drug lobby, ousted By John Wilkerson Adobe The generic drug industry’s lobbying group, the Association for Accessible Medicines, fired its president Dan Leonard, three sources said. Read More STAT+: The health insurer will see you now: How UnitedHealth is keeping more profits, as your doctor By Bob Herman Adobe UnitedHealth Group expects to funnel more of the insurance premiums it collects from workers and taxpayers toward itself next year. Read More Sponsored Insight by Pfizer Why scientists are sprinting toward new treatments for blood disorders Millions of people around the world suffer from blood disorders today, while scientists race to find new treatments and potential cures. In December, blood disorder specialists from around the globe will convene in New Orleans to share research and medical advances at the 64th annual meeting of the American Society of Hematology. Among them will be Pfizer scientists, who will be sharing more than 30 abstracts across Pfizer's hematology portfolio. Learn more about what they have to say. Opinion: Congress needs to update FDA's ability to regulate diagnostic tests, cosmetics By Scott Gottlieb and Mark B. McClellan ARIS MESSINIS/AFP via Getty Images By passing proposed legislation, Congress would help the FDA gain better oversight of diagnostic tests and cosmetics. Read More Medical malpractice lawsuits, delayed by the pandemic, are hitting hospitals harder than expected By Tara Bannow Adobe Medical malpractice lawsuits were held up as court dockets ground to a halt during the pandemic. Now, they're catching up with hospitals. Read More Monday, December 5, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser